Flood resilience depends on more than identifying where water flows. It requires engineering judgment, regulatory awar ...

Revolution Medicines recently made history with the approval of its RAS inhibitor Rasonque for advanced pancreatic cancer. But behind RevMed is an entire field of biotechs working to broaden the reach ...

The U.S. Food and Drug Administration (FDA) has approved daraxonrasib, an oral multi-selective RAS(ON) inhibitor, for adults with metastatic pancreatic adenocarcinoma who have received at least one ...

The FDA has approved the first RAS-targeted therapy for metastatic pancreatic cancer, offering a new treatment option for patients with previously treated disease. Daraxonrasib (Rasonque, Revolution ...

A model of the coming companion span for the Brent Spence Bridge at the Cincinnati Museum Center. The Cincinnati Museum Center's newest display has seen some things — namely, engineers blasting it ...

A scaled-down replica of the Brent Spence Companion Bridge is now on display at the museum center, offering a detailed look at its engineering and aerodynamic testing. At a "140-to-1 scale," the model ...

Unmanned Surface Vessel Division 12 (Sea Hunter) and 13 (Sea Hunter) conduct unit level training underway in San Diego Bay, California, May 1, 2025. US Navy photo The Navy’s portfolio acquisition ...

Eligibility estimates contract from ~13.3 million with obesity/overweight to ~3.8 million Bridge-eligible Part D enrollees after excluding diabetes, OSA, MASH, and current GLP‑1 users. Modeled ...

Tesla has launched the Model Y L, its stretched, three-row, six-seat SUV, in the US and Puerto Rico. The automaker confirmed the launch on Thursday, with the vehicle now configurable online. The Model ...

Implementation sits outside Part D, with Humana handling PA, adjudication, and reimbursement; manufacturers provide a $245 net price for Wegovy, Zepbound, and orforglipron. Eligibility requires PA and ...